Tech Company Financing Transactions
Perosphere Funding Round
On 2/4/2016, Perosphere raised $4.1 million in Series B investment from private investors.
Transaction Overview
Company Name
Announced On
2/4/2016
Transaction Type
Venture Equity
Amount
$4,089,000
Round
Series B
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 42 investors participated in the offering as amended. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
20 Kenosia Ave.
Danbury, CT 06810
USA
Danbury, CT 06810
USA
Phone
Website
Email Address
Overview
Perosphere is a specialty pharmaceutical company with internationally recognized drug delivery expertise. Perosphere identifies market opportunities where application of drug delivery technology to a drug already on the market can create a new medical use for that drug or enhance its safety, efficacy or ease of use.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Solomon Steiner
Chief Medical Officer
James Costin
Chief Technical Officer
Sasha Bakhru
VP - Bus. Development
Peter van Straelen
VP - Finance
Philip Sussman
VP - R & D
Bryan Laulicht
VP - Regulatory Affairs
Robert Hauser
Browse more venture capital transactions:
Prev: 2/4/2016: Siftery venture capital transaction
Next: 2/4/2016: Opendoor venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs